Interestingly, diminished PRDM1 expression is linked to poor survival and aggravated pathological grade of human glioma [15] and IL-33 is found to express heterogeneously in cancerous tissues and shares an association with inferior survival in patients suffered from relapse GBM [16]. Here, IL33 is linked to central nervous system cancer.